News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Adherence news

Show

From To
Adherence
European Commission Approves PREZISTA® (Darunavir) 800mg Tablet Once A Day

Janssen R&D Ireland has announced that the European Commission (EC) has approved a new PREZISTA(R) (darunavir) 800mg tablet allowing people living with HIV to take one darunavir tablet once a day.

Published
18 January 2013
From
HIV / AIDS News From Medical News Today
Finance and funding
Reaction to BBC reporting on generic ARVs

Yesterday the BBC issued a misleading news report on the efficacy of generic antiretroviral drugs (ARVs) suggesting that generic ARVs are less efficacious than branded alternatives. The report, based upon a study led by Massachusetts General Hospital (MGH) and Weill Cornell Medical College investigators, fails to separate the issues of ‘treatment efficacy’ and ‘adherence’ leading to distorted and alarmist conclusions.

Published
17 January 2013
From
Stop AIDS Campaign
Adherence
Reviews Show Little Evidence Of Widespread Efficacy Of Mobile Health Interventions

Mobile phone technology is frequently heralded as a solution to many health challenges facing the developing world, but two systematic reviews have found that evidence to back such claims is still largely non-existent.

Published
17 January 2013
From
Kaiser Daily Global Health Policy Report
Access to medicines and treatment
ZIMBABWE: Still struggling with drug shortages

Chronic shortages of generic and antiretroviral drugs, stock-outs, high medication costs, and long distances to clinics are some of the hurdles people face in their quest to access essential medicines in Zimbabwe.

Published
11 January 2013
From
IRIN Plus News
Adherence
Phone texts fail to boost adherence to HIV therapy

Mobile phone text messaging does not considerably enhance HIV/AIDS patients' adherence to treatment, a study conducted in Cameroon reveals.

Published
10 January 2013
From
SciDev NET
Treatment-experienced people
Any reduction in viral load has immunologic benefits for people with HIV who have triple-class treatment failure

HIV therapy that achieves even modest reductions in viral load can have profound immunological benefits for people with triple-class treatment failure, European investigators report in the online edition

Published
08 January 2013
By
Michael Carter
Adherence
Neurocognitive impairment results in poorer adherence to HIV therapy

Neurocognitive impairment and problems with memory are associated with poorer adherence to antiretroviral therapy, investigators from the United States report in the online edition of the Journal

Published
07 January 2013
By
Michael Carter
Hepatitis C treatment
Adherence to hepatitis C treatment: unravelling the complexities

Successful adherence to hepatitis C treatment may require physicians and care teams to address a wide range of factors, according to research from the United States and Germany

Published
13 December 2012
By
Rob Camp
Adherence
Out-of-clinic adherence club for delivery of ARVs shows better retention than standard of care

An out-of-clinic model of HIV treatment delivery in South Africa has shown superior results to the standard in-clinic delivery of antiretrovirals (ARVs), according to results of

Published
03 December 2012
By
Lesley Odendal
Adherence
Poor adherence costs pharma $564 billion per year

Drugmakers are losing out on hundreds of billions of dollars as a result of patients not taking their medication. That is the main finding of a report published by Capgemini Consulting and HealthPrize Technologies.

Published
28 November 2012
From
Pharma Times
← Prev12345...26Next →

Filter by country